Next Article in Journal
Facilitators and Barriers to Take up a COVID-19 Vaccine Booster Dose among Community-Dwelling Older Adults in Hong Kong: A Population-Based Random Telephone Survey
Next Article in Special Issue
Short-Term Side Effects and SARS-CoV-2 Infection after COVID-19 Pfizer–BioNTech Vaccine in Children Aged 5–11 Years: An Italian Real-World Study
Previous Article in Journal
Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy
Previous Article in Special Issue
Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection
 
 
Brief Report

Article Versions Notes

Vaccines 2022, 10(6), 965; https://doi.org/10.3390/vaccines10060965
Action Date Notes Link
article xml file uploaded 17 June 2022 05:23 CEST Original file -
article xml uploaded. 17 June 2022 05:23 CEST Update https://www.mdpi.com/2076-393X/10/6/965/xml
article pdf uploaded. 17 June 2022 05:24 CEST Version of Record https://www.mdpi.com/2076-393X/10/6/965/pdf
article supplementary file uploaded. 17 June 2022 05:24 CEST - https://www.mdpi.com/2076-393X/10/6/965#supplementary
article html file updated 17 June 2022 05:25 CEST Original file -
article html file updated 12 August 2022 20:53 CEST Update https://www.mdpi.com/2076-393X/10/6/965/html
Back to TopTop